Segin Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 2021.
2021 Delhi, Delhi, India Active
Last Updated:
Access Report
About Segin Pharmaceutical Private Limited

Segin Pharmaceutical Private Limited, a active private limited company, was established on 24 June 2021 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24239DL2021PTC382689. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Neeraj Sinha (Director), Ankit Kumar Malviya (Director), Ritu Kumari (Director). It is based at B-22, Block-B Lower Ground Floor, Jangpura Extension,, Delhi, Delhi, 110014.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239DL2021PTC382689

  • Registration Number

    382689

  • Incorporation Date

    24 June 2021

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 7 Months
Company report

Segin Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Segin Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Segin Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Neeraj Sinha Director 24 Jun 2021 Current
Ankit Kumar Malviya Director 24 Jun 2021 Current
Ritu Kumari Director 24 Jun 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Segin Pharmaceutical.

Enhance accessibility to Segin Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Segin Pharmaceutical revenue growth over time
Segin Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Segin Pharmaceutical?

Unlock access to Segin Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Segin Pharmaceutical?

Segin Pharmaceutical has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Segin Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Segin Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Segin Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    Neeraj Sinha was appointed as a Director was appointed as a Director on 24 Jun 2021 & has been associated with this company since 4 years 7 months . was recorded as a recent event.

  • Director Appointment

    Progress on Ankit Kumar Malviya was appointed as a Director was appointed as a Director on 24 Jun 2021 & has been associated with this company since 4 years 7 months . was documented.

  • Director Appointment

    Ritu Kumari was appointed as a Director was appointed as a Director on 24 Jun 2021 & has been associated with this company since 4 years 7 months . was recorded as a recent event.

  • Company Incorporation

    Segin Pharmaceutical Private Limited was registered on 24 Jun 2021 with Roc Delhi & aged 4 years 7 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Segin Pharmaceutical Private Limited?

The CIN of Segin Pharmaceutical Private Limited is U24239DL2021PTC382689.

Where is Segin Pharmaceutical Private Limited headquartered?

Segin Pharmaceutical Private Limited is headquartered at B-22, Block-B Lower Ground Floor, Jangpura Extension,, Delhi, Delhi, 110014.

When was Segin Pharmaceutical Private Limited incorporated?

Segin Pharmaceutical Private Limited was incorporated on 24 June 2021.

Who are the current directors of Segin Pharmaceutical Private Limited?

The current directors of Segin Pharmaceutical Private Limited are

What is the primary industry of Segin Pharmaceutical Private Limited?

The primary industry of Segin Pharmaceutical Private Limited is Pharma.

Is Segin Pharmaceutical Private Limited a listed company?

Segin Pharmaceutical Private Limited is unlisted.

What is the capital structure of Segin Pharmaceutical Private Limited?

The authorized capital of Segin Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available